Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms.
bleeding
medical treatment
stroke
thrombectomy
thrombolysis
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
16
03
2023
accepted:
09
06
2023
medline:
17
7
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Patients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectomy/ET and medical management alone published in full-text form (from 1980 to 2022). Collected variables included: First author name, covered study period, publication year, the total number of patients and age, number of males, presence of diabetes mellitus, hypertension, atrial fibrillation, prior ischemic stroke, location, NIHSS of admission, modified Rankin scale, bleeding, morbidity and mortality. After the initial search and applying all exclusion and inclusion criteria, eight articles were left in the final article pool. The total number of patients who underwent ET was 569, compared with 1097 with medical management for LVO strokes with minimal symptoms. The findings of the present meta-analysis study point out that ET management may be associated with a high risk of bleeding and mortality in patients with LVO presenting with mild symptoms (NIHSS score ≤8).
Identifiants
pubmed: 37456166
doi: 10.3892/etm.2023.12076
pii: ETM-26-2-12076
pmc: PMC10347103
doi:
Types de publication
Journal Article
Langues
eng
Pagination
377Informations de copyright
Copyright: © Anagnostopoulos et al.
Déclaration de conflit d'intérêts
DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article.
Références
Interv Neurol. 2018 Oct;7(6):431-438
pubmed: 30410521
Stroke. 2022 May;53(5):1674-1681
pubmed: 34872341
Stroke. 2015 Mar;46(3):909-14
pubmed: 25657185
Stroke. 2006 May;37(5):1332-3
pubmed: 16556881
Stroke. 2013 Apr;44(4):1153-7
pubmed: 23471266
Cerebrovasc Dis. 2009;27(2):160-6
pubmed: 19092237
Stroke. 2010 Dec;41(12):3007-8
pubmed: 21030695
World Neurosurg. 2021 May;149:e1140-e1154
pubmed: 33359881
J Neurointerv Surg. 2014 Jul;6(6):413-7
pubmed: 23843443
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Spec Pediatr Nurs. 2012 Jan;17(1):1-2
pubmed: 22188266
Int J Stroke. 2013 Jul;8(5):293-9
pubmed: 22568877
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
Cerebrovasc Dis. 2017;43(5-6):305-312
pubmed: 28384632
J Clin Neurosci. 2016 Aug;30:60-64
pubmed: 27050916
Stroke. 2018 Oct;49(10):2398-2405
pubmed: 30355094
Neurology. 2019 Oct 22;93(17):e1618-e1626
pubmed: 31591276
J Neurointerv Surg. 2017 Oct;9(10):917-921
pubmed: 27589861
J Neurointerv Surg. 2018 Apr;10(4):325-329
pubmed: 28768820
Circulation. 2011 Jun 7;123(22):2591-601
pubmed: 21646506
Med Sci Monit. 2020 Jul 06;26:e926110
pubmed: 32628645
Lancet Neurol. 2013 Aug;12(8):768-76
pubmed: 23791822
Lancet Neurol. 2016 Aug;15(9):913-924
pubmed: 27291521
J Am Heart Assoc. 2022 Dec 20;11(24):e027326
pubmed: 36533622
Stroke. 2018 Oct;49(10):2391-2397
pubmed: 30355086
Neurology. 2020 Dec 15;95(24):e3364-e3372
pubmed: 32989100
JAMA Neurol. 2020 Jan 1;77(1):16-24
pubmed: 31545353
N Engl J Med. 2013 Mar 7;368(10):893-903
pubmed: 23390923
Cerebrovasc Dis. 2014;38(6):418-24
pubmed: 25472576
Stroke. 2019 Aug;50(8):2037-2043
pubmed: 33755497